Omentin-1 Levels in Obesity
DOI:
https://doi.org/10.24293/ijcpml.v28i1.1737Keywords:
Obesity, omentin-1Abstract
Omentin-1 is an anti-inflammatory adipokine secreted by stromal vascular cells. Inflammation and apoptosis of adipocyte tissue in obesity lead to decreased production of omentin-1. This study aims to find the difference in omentin-1 levels in the obese and non-obese groups and the correlation between levels of omentin-1 with BMI and waist circumference. This study was a cross-sectional study involving 70 subjects with 37 people in the obese group and 33 people in the non-obese group. Anthropometric data including weight, height, waist circumference, and BMI were measured. Serum omentin-1 levels were measured by ELISA. The statistical tests used were Chi-square, T-test, Mann-Whitney test, and Spearman test. Test results were significant if p-value < 0.05. Significant difference was observed in serum omentin-1 levels between obese and non-obese group (median 140,31 range (88.08 – 382.76) vs. 210,97 range (124,44–577,96) ng/mL), respectively; p < 0.001). Serum omentin-1 correlated negatively with BMI (p=0.001, r = - 0.398) and waist circumference (p=0.017, r = - 0.286). Obesity causes inflammation and increased death of adipocyte tissues due to apoptosis, autophagy, and fibrosis resulting in decreased production of omentin-1 by stromal vascular cells. Anthropometric parameters of waist circumference and BMI describe the distribution of adipocyte tissue and affect the secretion of omentin-1. Omentin-1 levels in the obese group were lower than in the non-obese group. The higher the BMI and waist circumference, the lower the omentin-1 level.
Downloads
References
Ugur K, Sahin I, Aydin S. Biochemistry of obesity and its worldwide prevalence. Adv Biochem Biotehcnol, 2017; 2: 147.
Kinlen D, Cody D, O'Shea D. Complications of obesity. QJM: An International Journal of Medicine, 2018;
(7): 437-43.
Chooi YC, Ding C, Magkos F. The epidemiology of obesity. Metabolism, 2019; 92: 6-10.
Harbuwono DS, Pramono LA, Yunir E, Subekti I. Obesity and central obesity in Indonesia: Evidence
from a national health survey. Medical Journal of Indonesia, 2018; 27(2): 114-20.
Watanabe T, Watanabe"Kominato K, Takahashi Y, Kojima M, Watanabe R. Adipose tissue-derived
omentin"1 function and regulation. Comprehensive Physiology, 2017; 7(3): 765-81.
Chait A, den Hartigh LJ. Adipose tissue distribution, inflammation and its metabolic consequences,
including diabetes and cardiovascular disease. Frontiers in Cardiovascular Medicine, 2020; 7: 22.
Shi J, Fan J, Su Q, Yang Z. Cytokines and abnormal glucose and lipid metabolism. Frontiers in Endocrinology, 2019; 10: 703.
Cimen AR, Cerit ET, Iyidir OT, Karakus R, Uyar BB, et al. Serum omentin-1 levels and endothelial
dysfunction in obesity. Acta Endocrinologica (Bucharest), 2017; 13(2): 138.
Halabi s M, Dz iedz ic M, Warchulinska J, Kaznowska-Bystryk I, Solski J. Omentin-a new
adipokine with many roles to play. Current Issues in Pharmacy and Medical Sciences, 2015; 28(3): 176-80.
Landecho MF, Tuero C, ValentI V, Bilbao I, de la Higuera M, Fruhbeck G. Relevance of leptin and other
adipokines in obesity-associated cardiovascular risk. Nutrients, 2019; 11(11): 2664.
Shi J, Fan J, Su Q, Yang Z. Cytokines and abnormal glucose and lipid metabolism. Frontiers in
Endocrinology, 2019; 10: 703.
Alizadeh S, Mirzaei K, Mohammadi C, Keshavarz SA, Maghbooli Z. Circulating omentin-1 might be
associated with metabolic health status in different phenotypes of body size. Archives of Endocrinology
and Metabolism, 2017; 61(6): 567-74.
Elsaid NH, Sadik NA, Ahmed NR, Fayez SE, Mohammed NA. Serum omentin-1 levels in type 2
diabetic obese women in relation to glycemic control, insulin resistance and metabolic parameters.
Journal of Clinical & Translational Endocrinology, 2018; 13: 14-9.
Prasad DS, Kabir Z, Devi KR, Peter PS, Das BC. Gender differences in central obesity: Implications for
cardiometabolic health in South Asians. Indian Heart Journal, 2020; 72(3): 202-4.
Aras S, Ustunsoy S, Armutcu F. Indices of central and peripheral obesity; anthropometric measurements and laboratory parameters of metabolic syndrome and thyroid function. Balkan Med J, 2015; 32(4): 414.
Ouerghi N, Fradj MK, Bezrati I, Feki M, Kaabachi N, Bouassida A. Effect of high-intensity interval
training on plasma omentin-1 concentration in overweight/obese and normal-weight youth. Obesity
Facts, 2017; 10(4): 323-31.
Aliasghari F, Izadi A, Jabbari M, Imani B, Gargari BP, Asjodi F, Ebrahimi S. Are vaspin and omentin-1 related to insulin resistance, blood pressure and inflammation in NAFLD patients?. Journal of Medical Biochemistry, 2018; 37(4): 470.
Downloads
Submitted
Accepted
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
